Month: January 2026

Strengthening its “Compliance-First” foundation, OwlTing establishes a strategic node in Nevada to unlock high-volume global commerce ARLINGTON, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) — OBOOK Holdings Inc. (NASDAQ: OWLS) (the “Company” or “OwlTing”), a global fintech company operating as the OwlTing Group, today announced that it has obtained a Money Transmitter License (MTL)1 from the State of Nevada. This milestone expands the Company’s regulatory coverage to 41 U.S. states, marking a significant step in its mission to build a highly compliant, cross-border payment network for global enterprises. The Nevada license follows a rigorous and comprehensive regulatory review process. This achievement underscores OwlTing’s long-standing compliance-first strategy and its unwavering commitment to maintaining robust regulatory...

JACKSONVILLE, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) — Landstar System, Inc. (NASDAQ:LSTR), announced today it will release its 2025 fourth quarter results after the market closes on Wednesday, January 28, 2026, and will then hold its quarterly conference call with analysts and investors at 4:30 p.m. ET that evening to discuss the fourth quarter results. To access the webcast, visit investor.landstar.com; click on “Webcasts”; and then “Landstar’s Fourth Quarter 2025 Earnings Release Conference Call.” For those unable to participate in the live call, or for those who do not have access to the Internet, the call will be available on telephone replay for 48 hours. The telephone replay number for the U.S. and Canada is (800) 819-5743 and for international calls is (203) 369-3828. About Landstar: Landstar...

UAB “Kvartalas” aimed to raise 9,391,300 euros during the offering of the fifth tranche of bonds to finance the development of the “Sąvaržėlė” business centre on Konstitucijos ave. in Vilnius. The offering began on 13 January 2026 and was initially scheduled to run until 21 January. In this tranche, the Issuer had the right to shorten the offering period once it determined that sufficient investor demand has been reached, to ensure higher allocation to investors. The offering was completed on the first day (13 January), having reached 11.8 million euros in demand at nominal value – approximately 26 % of the amount initially offered. To ensure a diversified investor base, investor orders of up to EUR 15,000 were allocated in full. For investors seeking to purchase bonds in excess of EUR 15,000, the portion of the...

TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that it will release its financial results for the fourth quarter ended December 31, 2025 by press release on Wednesday, February 4, 2026 at approximately 7:30 am ET. The conference call to review these financial results will take place at 11:00 am ET on Wednesday, February 4, 2026, and will be hosted by D. Scott Patterson, CEO, and Jeremy Rakusin, CFO. This call is being webcast live at the Company’s website at www.firstservice.com. Participants may register for the call here https://register-conf.media-server.com/register/BI8ca41330dc1e42ddb03f81b1f7b5bca1 to receive the dial-in number and their unique PIN. To join the webcast in listen only mode, use this link: https://edge.media-server.com/mmc/p/87nnofzc...

Vancouver, BC, Jan. 14, 2026 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to announce results from its 2025 drilling campaign at its 100% owned 35,705 hectare Moore Uranium Project, located approximately 15 kilometres east of Denison Mines’ Wheeler River project in the Athabasca Basin, Saskatchewan. A total of twenty-one drill holes were completed totaling 7,884 metres in the latter part of last year. The drilling notably intersected high-grade uranium mineralization at the Main Maverick Zone with hole ML25-15, returning 4.84% U3O8 over 4.4 metres, including 11.77% U3O8 over 1.6 metres. Furthermore, Skyharbour successfully identified a new regional target area called the Nomad Zone approximately 1.7 kilometres to the southwest of the Main Maverick...

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cannara Biotech Inc. (TSX-V: LOVE.V; OTCQX: LOVFF FSX: 8CB;), a vertically integrated producer of premium-grade cannabis and cannabis-derivative products, has qualified to trade on the OTCQX® Best Market. Cannara Biotech Inc. upgraded to OTCQX from the OTCQB® Venture Market. Cannara Biotech Inc. begins trading today on OTCQX under the symbol “LOVFF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice...

Get a $5 General Admission Movie Ticket and $5 Small Popcorn Every Tuesday from January 20 to February 24TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) — (TSX: CGX) – Starting January 20, Cineplex’s $5 Tuesdays return for a limited time, running through February 24, 2026, giving Canadians a reason to turn a winter weeknight into a memorable night out. With a general admission movie ticket and a small bag of popcorn for just $5 each, plus tax, guests can enjoy great savings, escape the cold and share in the best way to watch a movie, surrounded by fellow movie lovers. Create the perfect setting for date night with popcorn and a movie for two for just $20, (in-theatre price). A family of four can bring the whole crew for just $40 (in-theatre price), and no one will have to fight over sharing their popcorn. Tickets can be purchased in-theatre...

 Cemsidomide Phase 2 MOMENTUM Trial On Track to Initiate in Q1 2026; Recommended Phase 2 Dose is 100 µg Cemsidomide Phase 1b Trial in Combination With Elranatamab On Track to Initiate in Q2 2026 Internal Discovery Strategy Progressing Efforts Focused on Inflammation, Neuro-inflammation and Neuro-degenerative Diseases With Novel Targets in Clinically Validated Pathways Cash Runway to End of 2028 Provides Funding Through Key Value Inflection Points WATERTOWN, Mass., Jan. 14, 2026 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today outlined milestones through 2028 and highlighted recent achievements. “We begin 2026 with compelling opportunities ahead, anchored by cemsidomide’s path to become a foundational medicine...

TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) is pleased to provide a year-end review of its key accomplishments in 2025 and an outlook on priorities for 2026. The past year marked a pivotal transition for Lithium Ionic, defined by continued mineral resource growth, the delivery of a materially improved feasibility study, strengthened technical leadership, and successful financing execution. Together, these milestones have positioned the Company to enter 2026 focused on advancing permitting to completion, finalizing detailed engineering, securing project financing, and progressing pre-development activities to advance its flagship Bandeira Lithium Project into the construction phase. With a robust technical foundation...